Inspire Medical Systems, Inc. (INSP) shareholders
Close on Nov 17, 2026Market cap $1.72BP/E 12.9Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 4,163,016 | 14.40% | 13G (passive) amendment | Jun 30, 2026 |
| Wellington Group Holdings LLP Joint filing with Wellington Management Group LLP (8.80%), Wellington Investment Advisors Holdings LLP (8.80%) and 1 more | 2,535,954 | 8.80% | 13G (passive) amendment | Mar 31, 2026 |
| Wellington Management Company LLP Joint filing with Wellington Management Group LLP (7.60%), Wellington Group Holdings LLP (7.60%) and 1 more | 2,211,091 | 7.30% | 13G (passive) | Dec 31, 2025 |
| AQR Capital Management Holdings, LLC Joint filing with AQR Capital Management, LLC (6.44%) | 1,856,800 | 6.44% | 13G (passive) | Jun 30, 2026 |
| Vanguard Portfolio Management | 1,741,113 | 6.02% | 13G (passive) amendment | Sep 30, 2026 |
| D. E. Shaw & Co., L.P. Joint filing with David E. Shaw (5.10%) | 1,483,107 | 5.10% | 13G (passive) | Jun 25, 2026 |
| Deerfield Mgmt, L.P. Joint filing with Deerfield Management Company, L.P. (5.08%), Deerfield Partners, L.P. (5.08%) and 1 more | 1,476,303 | 5.08% | 13G (passive) | Nov 6, 2025 |
| Vanguard Capital Management | 1,469,703 | 5.10% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of INSP | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4,737,519 | 16.39% | $211.34M | +1,187,965 | 0.00% |
| Wellington Management Group Llp | 2,382,660 | 8.24% | $106.29M | −153,294 | 0.02% |
| Vanguard Portfolio Management LLC | 2,088,961 | 7.23% | $93.19M | +451,788 | 0.00% |
| Soleus Capital Management, L.P. | 1,931,436 | 6.68% | $86.16M | +1,355,137 | 2.97% |
| Aqr Capital Management LLC | 1,856,800 | 6.42% | $80.94M | +1,548,138 | 0.03% |
| Assenagon Asset Management S.A. | 1,728,790 | 5.98% | $77.12M | +1,208,616 | 0.05% |
| UBS Group AG | 1,645,511 | 5.69% | $73.41M | +1,006,583 | 0.01% |
| D. E. Shaw & Co., Inc. | 1,470,462 | 5.09% | $65.60M | +281,925 | 0.03% |
| Nomura Holdings Inc | 1,369,410 | 4.74% | $61.09M | New | 0.07% |
| Deerfield Management Company, L.P. (Series C) | 1,296,862 | 4.49% | $57.85M | −1,406,376 | 0.60% |
| Vanguard Capital Management LLC | 1,270,928 | 4.40% | $56.70M | +4,190 | 0.00% |
| State Street Corp | 1,206,494 | 4.17% | $53.82M | +250,483 | 0.00% |
| Morgan Stanley | 791,222 | 2.74% | $35.30M | −659,412 | 0.00% |
| Artisan Partners Limited Partnership | 732,323 | 2.53% | $32.67M | −48,252 | 0.05% |
| Geode Capital Management, LLC | 700,836 | 2.42% | $31.27M | +190,602 | 0.00% |
| Braidwell LP | 677,570 | 2.34% | $30.23M | – | 1.12% |
| Goldman Sachs Group Inc | 645,858 | 2.23% | $28.81M | −18,145 | 0.00% |
| UBS Asset Management Americas Inc | 546,020 | 1.89% | $24.36M | +97,233 | 0.00% |
| Nantahala Capital Management, LLC | 538,948 | 1.86% | $24.04M | New | 0.40% |
| Citadel Advisors LLC | 506,334 | 1.75% | $22.59M | +112,258 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 275 | 38M | 100.0% | 69 / 97 | 76 / 90 | 13M | 10M |
| Q1 2026 | 301 | 35M | 100.0% | 59 / 119 | 100 / 94 | 11M | 7M |
| Q4 2025 | 343 | 35M | 100.0% | 93 / 115 | 113 / 69 | 12M | 8M |
| Q3 2025 | 325 | 31M | 100.0% | 66 / 96 | 133 / 94 | 10M | 13M |
| Q2 2025 | 356 | 34M | 100.0% | 48 / 131 | 141 / 52 | 4M | 4M |
| Q1 2025 | 363 | 34M | 100.0% | 58 / 141 | 113 / 50 | 4M | 3M |
| Q4 2024 | 357 | 33M | 100.0% | 60 / 119 | 127 / 44 | 4M | 5M |
| Q3 2024 | 347 | 34M | 100.0% | 80 / 116 | 109 / 55 | 8M | 5M |
| Q2 2024 | 325 | 32M | 100.0% | 71 / 120 | 99 / 70 | 7M | 6M |
| Q1 2024 | 327 | 33M | 100.0% | 43 / 124 | 108 / 55 | 5M | 4M |
| Q4 2023 | 343 | 32M | 100.0% | 64 / 120 | 121 / 80 | 9M | 6M |
| Q3 2023 | 364 | 28M | 98.5% | 49 / 145 | 121 / 88 | 6M | 6M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
266 funds held INSP in Q2 2026, 58% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of INSP | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Health Care Fund | 2,093,826 | 7.24% | $105.13M | 0.28% | Jul 31, 2026 |
| iShares Core S&P Small-Cap ETF | 1,580,006 | 5.47% | $70.48M | 0.06% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 914,149 | 3.16% | $40.78M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 750,558 | 2.60% | $33.48M | 0.04% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 660,263 | 2.28% | $29.45M | 0.02% | Jun 30, 2026 |
| Artisan International Small-Mid Fund | 456,014 | 1.58% | $20.34M | 0.80% | Jun 30, 2026 |
| Vanguard Small-Cap Growth Index Fund | 379,022 | 1.31% | $16.91M | 0.04% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 317,411 | 1.10% | $15.94M | 0.05% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 302,273 | 1.05% | $13.48M | 0.01% | Jun 30, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF | 240,113 | 0.83% | $10.71M | 0.06% | Jun 30, 2026 |
| Federated Hermes MDT Mid Cap Growth Fund | 236,764 | 0.82% | $11.89M | 0.18% | Jul 31, 2026 |
| iShares S&P Small-Cap 600 Growth ETF | 234,886 | 0.81% | $10.48M | 0.13% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF | 232,083 | 0.80% | $10.35M | 0.07% | Jun 30, 2026 |
| Vanguard Strategic Equity Fund | 230,603 | 0.80% | $10.29M | 0.08% | Jun 30, 2026 |
| Vanguard Explorer Fund | 182,216 | 0.63% | $9.15M | 0.04% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Timothy P. Herbert | CEO and President, Director | 105,349 | 0.36% | Feb 24, 2026 |
| Jason P. Kelly | See Remarks | 25,335 | 0.09% | Sep 2, 2026 |
| Melissa Mann | Chief People Officer | 22,957 | 0.08% | Aug 4, 2026 |
| John Rondoni | See Remarks | 27,165 | 0.09% | May 19, 2026 |
| Bryan K. Phillips | See Remarks | 38,513 | 0.13% | Feb 24, 2026 |
| Carlton Weatherby | See Remarks | 41,679 | 0.14% | Feb 24, 2026 |
| Matthew J. Osberg | Chief Financial Officer | 19,794 | 0.07% | Feb 24, 2026 |
| Richard Buchholz | Interim CFO | 45,463 | 0.16% | Feb 18, 2026 |
| Randy Ban | See Remarks | 9,303 | 0.03% | Mar 5, 2025 |
| Michael H. Carrel | Director | 5,834 | 0.02% | Oct 16, 2026 |
| Shelley G. Broader | Director | 9,138 | 0.03% | Oct 16, 2026 |
| Georgia Melenikiotou | Director | 8,584 | 0.03% | Oct 16, 2026 |
| Gary Lee Ellis | Director | 11,850 | 0.04% | Oct 16, 2026 |
| Casey M. Tansey | Director | 27,132 | 0.09% | Jul 17, 2026 |
| Shawn mcCormick | Director | 30,712 | 0.11% | May 11, 2026 |
| Cynthia Burks | Director | 6,213 | 0.02% | May 4, 2026 |
| Dana G. Mead Jr. | Director | 26,213 | 0.09% | May 4, 2026 |
| Myriam Curet | Director | 6,927 | 0.02% | May 4, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Gary Lee Ellis Director | Oct 14, 2026 | Award | +431 | $68.07 | $29.34K | 11,850 |
| Georgia Melenikiotou Director | Oct 14, 2026 | Award | +255 | $68.07 | $17.36K | 8,584 |
| Michael H. Carrel Director | Oct 14, 2026 | Award | +203 | $68.07 | $13.82K | 5,834 |
| Shelley G. Broader Director | Oct 14, 2026 | Award | +284 | $68.07 | $19.33K | 9,138 |
| Jason P. Kelly See Remarks | Aug 31, 2026 | Award | +6,350 | – | – | 25,335 |
| Jason P. Kelly See Remarks | Aug 7, 2026 | Sale | −963 | $59.55 | $57.35K | 18,985 |
| Melissa Mann Chief People Officer | Jul 31, 2026 | Tax withholding | −326 | $50.21 | $16.37K | 22,957 |
| Michael H. Carrel Director | Jul 20, 2026 | Award | +5,631 | – | – | 5,631 |
| Shelley G. Broader Director | Jul 15, 2026 | Award | +383 | – | – | 8,854 |
| Georgia Melenikiotou Director | Jul 15, 2026 | Award | +344 | – | – | 8,329 |
| Casey M. Tansey Director | Jul 15, 2026 | Award | +346 | – | – | 26,632 |
| Gary Lee Ellis Director | Jul 15, 2026 | Award | +581 | – | – | 11,419 |
| John Rondoni See Remarks | May 15, 2026 | Sale | −2,641 | $43.28 | $114.30K | 27,165 |
| John Rondoni See Remarks | May 14, 2026 | Sale | −700 | $43.01 | $30.11K | 29,806 |
| Shawn mcCormick Director | May 8, 2026 | Sale(10b5-1 plan) | −696 | $45.31 | $31.54K | 27,712 |
| Georgia Melenikiotou Director | May 1, 2026 | Tax withholding | −50 | $56.70 | $2.84K | 7,985 |
| Dana G. Mead Jr. Director | Apr 30, 2026 | Award | +3,562 | – | – | 26,213 |
| Georgia Melenikiotou Director | Apr 30, 2026 | Award | +3,562 | – | – | 8,035 |
| Shelley G. Broader Director | Apr 30, 2026 | Award | +3,562 | – | – | 8,471 |
| Myriam Curet Director | Apr 30, 2026 | Award | +3,562 | – | – | 6,927 |
| Cynthia Burks Director | Apr 30, 2026 | Award | +3,562 | – | – | 6,213 |
| Gary Lee Ellis Director | Apr 30, 2026 | Award | +3,562 | – | – | 10,838 |
| Casey M. Tansey Director | Apr 30, 2026 | Award | +3,562 | – | – | 26,286 |
| Shawn mcCormick Director | Apr 30, 2026 | Award | +3,562 | – | – | 28,408 |
| Gary Lee Ellis Director | Apr 15, 2026 | Award | +518 | $52.07 | $26.97K | 7,276 |
| Casey M. Tansey Director | Apr 15, 2026 | Award | +308 | $52.07 | $16.04K | 22,724 |
| Georgia Melenikiotou Director | Apr 15, 2026 | Award | +307 | $52.07 | $15.99K | 4,473 |
| Shelley G. Broader Director | Apr 15, 2026 | Award | +342 | $52.07 | $17.81K | 4,909 |
| Jason P. Kelly See Remarks | Feb 20, 2026 | Award | +15,958 | – | – | 19,948 |
| Timothy P. Herbert CEO and President, Director | Feb 20, 2026 | Award | +9,005 | – | – | 41,691 |
| Timothy P. Herbert CEO and President, Director | Feb 20, 2026 | Tax withholding | −4,010 | $59.53 | $238.72K | 37,681 |
| Timothy P. Herbert CEO and President, Director | Feb 20, 2026 | Award | +62,153 | – | – | 99,834 |
| Carlton Weatherby See Remarks | Feb 20, 2026 | Award | +12,598 | – | – | 41,679 |
| Carlton Weatherby See Remarks | Feb 20, 2026 | Award | +20,997 | – | – | 29,081 |
| Carlton Weatherby See Remarks | Feb 20, 2026 | Tax withholding | −672 | $59.53 | $40.00K | 8,084 |
| Carlton Weatherby See Remarks | Feb 20, 2026 | Award | +2,196 | – | – | 8,756 |
| Bryan K. Phillips See Remarks | Feb 20, 2026 | Award | +8,399 | – | – | 38,513 |
| Bryan K. Phillips See Remarks | Feb 20, 2026 | Award | +15,958 | – | – | 30,114 |
| Bryan K. Phillips See Remarks | Feb 20, 2026 | Tax withholding | −735 | $59.53 | $43.75K | 14,156 |
| Bryan K. Phillips See Remarks | Feb 20, 2026 | Award | +2,400 | – | – | 14,891 |
| John Rondoni See Remarks | Feb 20, 2026 | Award | +2,400 | – | – | 15,283 |
| John Rondoni See Remarks | Feb 20, 2026 | Tax withholding | −735 | $59.53 | $43.75K | 14,548 |
| John Rondoni See Remarks | Feb 20, 2026 | Award | +15,958 | – | – | 30,506 |
| Melissa Mann Chief People Officer | Feb 20, 2026 | Award | +15,958 | – | – | 23,609 |
| Carlton Weatherby See Remarks | Feb 13, 2026 | Tax withholding | −570 | $59.76 | $34.06K | 6,560 |
| John Rondoni See Remarks | Feb 13, 2026 | Tax withholding | −587 | $59.76 | $35.08K | 12,883 |
| Bryan K. Phillips See Remarks | Feb 13, 2026 | Tax withholding | −579 | $59.76 | $34.60K | 12,491 |
| Melissa Mann Chief People Officer | Feb 13, 2026 | Tax withholding | −615 | $59.76 | $36.75K | 7,651 |
| Richard Buchholz Interim CFO | Feb 13, 2026 | Tax withholding | −579 | $59.76 | $34.60K | 43,988 |
| Jason P. Kelly See Remarks | Feb 13, 2026 | Tax withholding | −551 | $59.76 | $32.93K | 3,990 |
| Timothy P. Herbert CEO and President, Director | Feb 13, 2026 | Tax withholding | −1,635 | $59.76 | $97.71K | 32,686 |
| Carlton Weatherby See Remarks | Feb 9, 2026 | Tax withholding | −327 | $66.33 | $21.69K | 7,130 |
| John Rondoni See Remarks | Feb 9, 2026 | Tax withholding | −327 | $66.33 | $21.69K | 13,470 |
| Timothy P. Herbert CEO and President, Director | Feb 9, 2026 | Tax withholding | −968 | $66.33 | $64.21K | 34,321 |
| Bryan K. Phillips See Remarks | Feb 9, 2026 | Tax withholding | −327 | $66.33 | $21.69K | 13,070 |
| Richard Buchholz Interim CFO | Feb 9, 2026 | Tax withholding | −327 | $66.33 | $21.69K | 44,567 |
| Shelley G. Broader Director | Jan 15, 2026 | Award | +200 | $96.47 | $19.29K | 4,567 |
| Casey M. Tansey Director | Jan 15, 2026 | Award | +181 | $96.47 | $17.46K | 22,416 |
| Georgia Melenikiotou Director | Jan 15, 2026 | Award | +180 | $96.47 | $17.36K | 4,166 |
| Gary Lee Ellis Director | Jan 15, 2026 | Award | +304 | $96.47 | $29.33K | 6,758 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Inspire Medical Systems's stock actually held short. Settlement fails (shares not delivered on time) peaked at 268,784 shares on Oct 14, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| John Rondoni Officer | Aug 24, 2026 | 64 | $3.99K | Aug 24, 2026 | Employee Stock Purchase Plan |
| Jason P. Kelly Officer | Aug 7, 2026 | 963 | $57.34K | Aug 7, 2026 | Restricted Stock |
| John Rondoni Officer | May 15, 2026 | 2,641 | $114.30K | May 15, 2026 | Restricted stock vesting under a registered plan |
| John Rondoni Officer | May 14, 2026 | 700 | $30.11K | May 14, 2026 | Restricted stock vesting under a registered plan |
| Shawn mcCormick Director | May 8, 2026 | 696 | $31.72K | May 8, 2026 | Restricted Stock Units |
| John Rondoni Officer | Jan 9, 2026 | 109 | $10.36K | Jan 9, 2026 | Employee Stock Purchase Plan |
| Shawn mcCormick Director | Dec 2, 2025 | 1,200 | $151.61K | Dec 2, 2025 | Previously Exercised Stock Options |
| Shawn mcCormick Director | Nov 28, 2025 | 2,000 | $254.66K | Nov 28, 2025 | Previously Exercised Stock Options |
| Richard Buchholz Officer | Aug 29, 2025 | 11,000 | $1.03M | Aug 29, 2025 | OPTION EXERCISE |
| John Rondoni Officer | May 19, 2025 | 1,734 | $259.02K | May 19, 2025 | Exercised Shares |
| Shawn mcCormick Director | May 2, 2025 | 360 | $56.84K | May 2, 2025 | Restricted Stock Units |
| John Rondoni Officer | Mar 3, 2025 | 2,287 | $424.47K | Mar 3, 2025 | Performance Shares |
| Randall Ban Officer | Feb 28, 2025 | 3,947 | $726.33K | Feb 28, 2025 | Performance Stock Units |
| Randall Ban Officer | Feb 13, 2025 | 25,584 | $4.78M | Feb 13, 2025 | Exercise of Stock Options |
| John Rondoni Officer | Feb 11, 2025 | 583 | $99.40K | Feb 11, 2025 | Restricted Stock |
Congress trades
1 trade in Inspire Medical Systems reported by 1 member of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Daniel Goldman NY10 | Sold (part) | Apr 10, 2023 | $1K–15K | May 19, 2023 |
See a number that looks wrong?